[HTML][HTML] Stem cell-based therapy for human diseases
DM Hoang, PT Pham, TQ Bach, ATL Ngo…�- Signal transduction and�…, 2022 - nature.com
Recent advancements in stem cell technology open a new door for patients suffering from
diseases and disorders that have yet to be treated. Stem cell-based therapy, including�…
diseases and disorders that have yet to be treated. Stem cell-based therapy, including�…
[HTML][HTML] Risk and protective factors for COVID-19 morbidity, severity, and mortality
J Zhang, X Dong, G Liu, Y Gao�- Clinical reviews in allergy & immunology, 2023 - Springer
The outbreak of the coronavirus disease 2019 (COVID-19), caused by the novel severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has become an evolving global�…
acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has become an evolving global�…
[HTML][HTML] Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3�…
Early increase of soluble urokinase plasminogen activator receptor (suPAR) serum levels is
indicative of increased risk of progression of coronavirus disease 2019 (COVID-19) to�…
indicative of increased risk of progression of coronavirus disease 2019 (COVID-19) to�…
[HTML][HTML] From SARS and MERS to COVID-19: a brief summary and comparison of severe acute respiratory infections caused by three highly pathogenic human�…
Z Zhu, X Lian, X Su, W Wu, GA Marraro, Y Zeng�- Respiratory research, 2020 - Springer
Within two decades, there have emerged three highly pathogenic and deadly human
coronaviruses, namely SARS-CoV, MERS-CoV and SARS-CoV-2. The economic burden�…
coronaviruses, namely SARS-CoV, MERS-CoV and SARS-CoV-2. The economic burden�…
[HTML][HTML] Severe COVID-19 is marked by a dysregulated myeloid cell compartment
J Schulte-Schrepping, N Reusch, D Paclik, K Ba�ler…�- Cell, 2020 - cell.com
Summary Coronavirus disease 2019 (COVID-19) is a mild to moderate respiratory tract
infection, however, a subset of patients progress to severe disease and respiratory failure�…
infection, however, a subset of patients progress to severe disease and respiratory failure�…
Demographic risk factors for COVID-19 infection, severity, ICU admission and death: a meta-analysis of 59 studies
Objective We aimed to describe the associations of age and sex with the risk of COVID-19 in
different severity stages ranging from infection to death. Design Systematic review and meta�…
different severity stages ranging from infection to death. Design Systematic review and meta�…
[HTML][HTML] Aging, immunity, and COVID-19: how age influences the host immune response to coronavirus infections?
V Bajaj, N Gadi, AP Spihlman, SC Wu, CH Choi…�- Frontiers in�…, 2021 - frontiersin.org
The novel coronavirus severe acute respiratory syndrome coronavirus 2 causing the
Coronavirus disease (COVID-19) pandemic has ravaged the world with over 72 million total�…
Coronavirus disease (COVID-19) pandemic has ravaged the world with over 72 million total�…
[HTML][HTML] Corticosteroid use in COVID-19 patients: a systematic review and meta-analysis on clinical outcomes
J Van Paassen, JS Vos, EM Hoekstra, KMI Neumann…�- Critical Care, 2020 - Springer
Background In the current SARS-CoV-2 pandemic, there has been worldwide debate on the
use of corticosteroids in COVID-19. In the recent RECOVERY trial, evaluating the effect of�…
use of corticosteroids in COVID-19. In the recent RECOVERY trial, evaluating the effect of�…
Covid-19 and autoimmunity
Though the exact etiology of autoimmune diseases still remains unknown, there are various
factors which are believed to contribute to the emergence of an autoimmune disease in a�…
factors which are believed to contribute to the emergence of an autoimmune disease in a�…
[HTML][HTML] Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors
M Ripa, L Galli, A Poli, C Oltolini, V Spagnuolo…�- Clinical Microbiology�…, 2021 - Elsevier
Objectives The aim of our study was to describe the incidence and predictive factors of
secondary infections in patients with coronavirus disease 2019 (COVID-19). Methods This�…
secondary infections in patients with coronavirus disease 2019 (COVID-19). Methods This�…